EZZ Life Science Holdings Ltd. ( (AU:EZZ) ) has shared an announcement.
EZZ Life Science Holdings Ltd has entered into a manufacturing agreement with GLSP Inc. to produce dietary supplements in the United States, marking a significant milestone in its North American expansion strategy. This partnership is expected to enhance production efficiencies, improve supply chain logistics, and strengthen EZZ’s market positioning in the region, aligning with the company’s strategy to meet the growing demand for high-quality, science-backed health supplements.
More about EZZ Life Science Holdings Ltd.
EZZ Life Science Holdings Ltd is a genomic life science company focused on improving quality of life and human health through the production of nutrition supplements. The company is dedicated to expanding its global manufacturing and distribution capabilities, particularly in the North American market.
YTD Price Performance: -43.65%
Average Trading Volume: 63,070
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$81.61M
Learn more about EZZ stock on TipRanks’ Stock Analysis page.